Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (191-200 of 322) with videos related to

Pageof 33
Sort By:
JAMA Oncology|February 17, 2018
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A ReviewStuart E Siegel, Wendy Stock, Rebecca H Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Journal of Hematology & Oncology|January 7, 2018
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemiaAmy Y Wang, Howard Weiner, Margaret Green, et al.
Cancer Cell|May 6, 2014
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemiaChong Chen, Yu Liu, Amy R Rappaport, et al.
Leukemia & Lymphoma|September 15, 2011
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML)Sarah M Larson, Nicholas P Campbell, Dezheng Huo, et al.
British Journal of Haematology|February 18, 2014
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapySteven E Coutre, Megan Othus, Bayard Powell, et al.
Leukemia & Lymphoma|October 24, 2012
Immune reconstitution after combined haploidentical and umbilical cord blood transplantNitin Jain, Hongtao Liu, Andrew S Artz, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
Haematologica|February 13, 2016
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survivalKoen van Besien, Parameswaran Hari, Mei-Jie Zhang, et al.
British Journal of Haematology|October 27, 2025
Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapiesMiles Thomas, Hannah Johnston, Emily Dworkin, et al.
Pageof 33

Showing results (191-200 of 322) with videos related to

Sort By:
Pageof 33
JAMA Oncology|February 17, 2018
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A ReviewStuart E Siegel, Wendy Stock, Rebecca H Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Journal of Hematology & Oncology|January 7, 2018
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemiaAmy Y Wang, Howard Weiner, Margaret Green, et al.
Cancer Cell|May 6, 2014
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemiaChong Chen, Yu Liu, Amy R Rappaport, et al.
Leukemia & Lymphoma|September 15, 2011
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML)Sarah M Larson, Nicholas P Campbell, Dezheng Huo, et al.
British Journal of Haematology|February 18, 2014
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapySteven E Coutre, Megan Othus, Bayard Powell, et al.
Leukemia & Lymphoma|October 24, 2012
Immune reconstitution after combined haploidentical and umbilical cord blood transplantNitin Jain, Hongtao Liu, Andrew S Artz, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
Haematologica|February 13, 2016
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survivalKoen van Besien, Parameswaran Hari, Mei-Jie Zhang, et al.
British Journal of Haematology|October 27, 2025
Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapiesMiles Thomas, Hannah Johnston, Emily Dworkin, et al.
Pageof 33